ITM Secures Up to $262.5M in Non-Dilutive Debt Financing with Blue Owl Managed Funds

| Posted on |

Here’s the list extracted from the provided text:

Company and Founders

  • Startup: ITM Isotope Technologies Munich SE
  • Founders: Dr. Andrew Cavey (CEO)

Funding Details

  • Funds/Investors: Blue Owl Capital
  • Fundraise Series: Debt financing
  • Amount Raised: Up to $262.5M

Dates

  • Date of Fundraise Announcement: 27/05/2025

Additional Information

  • The funds will be used for commercial readiness and potential market launch of the lead candidate, n.c.a. 177Lu-edotreotide (ITM-11).

Source link

2025-05-27 10:37:08